Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotterdam Antiplatelet Therapy in Vascular Patients Study
NL-OMON46172Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in atherosclerotic disease, arteriosclerosis and thrombosis comparing Clopidogrel plus aspirin with Placebo plus aspirin (2 arms). Primary endpoint: Major adverse cardiovascular events. Started Aug 2016; status: active, not recruiting.
02
Drugs
clopidogrelaspirin
03
Conditions
atherosclerotic diseasearteriosclerosisthrombosis
Beyond the preview
Go deeper on NL-OMON46172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46172.